Evidence map›Paper›PMID 29490628›Full record

ArticleBMC bioinformatics2018

Variance component analysis to assess protein quantification in biomarker validation: application to selected reaction monitoring-mass spectrometry.

Amna Klich, Catherine Mercier, Laurent Gerfault, Pierre Grangeat, Corinne Beaulieu, Elodie Degout-Charmette, Tanguy Fortin, Pierre Mahé, Jean-François Giovannelli, Jean-Philippe Charrier and 3 more

Abstract read
In one paragraph

Article in BMC bioinformatics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Amna KlichService de Biostatistique-Bioinformatique, Hospices Civils de Lyon, 162, avenue Lacassagne, F-69003, Lyon, France. amna.klich@chu-lyon.fr.
Catherine MercierService de Biostatistique-Bioinformatique, Hospices Civils de Lyon, 162, avenue Lacassagne, F-69003, Lyon, France.
Laurent GerfaultUniversité Grenoble-Alpes, F-38000, Grenoble, France.
Pierre GrangeatUniversité Grenoble-Alpes, F-38000, Grenoble, France.
Corinne BeaulieuInnovation Unit, Technology Research Department, bioMérieux, F-69280, Marcy l'Étoile, France.
Elodie Degout-CharmetteInnovation Unit, Technology Research Department, bioMérieux, F-69280, Marcy l'Étoile, France.
Tanguy FortinInnovation Unit, Technology Research Department, bioMérieux, F-69280, Marcy l'Étoile, France.
Pierre MahéInnovation Unit, Technology Research Department, bioMérieux, F-38000, Grenoble, France.
Jean-François GiovannelliIntégration du Matériau au Système (Université de Bordeaux, CNRS, Bordeaux Aquitaine INP), F-33400, Talence, France.
Jean-Philippe CharrierInnovation Unit, Technology Research Department, bioMérieux, F-69280, Marcy l'Étoile, France.
Audrey GiremusIntégration du Matériau au Système (Université de Bordeaux, CNRS, Bordeaux Aquitaine INP), F-33400, Talence, France.
Delphine Maucort-BoulchService de Biostatistique-Bioinformatique, Hospices Civils de Lyon, 162, avenue Lacassagne, F-69003, Lyon, France.
Pascal RoyService de Biostatistique-Bioinformatique, Hospices Civils de Lyon, 162, avenue Lacassagne, F-69003, Lyon, France.

Funding

Agence Nationale de la Recherche BLAN 0313
6 · The paper itself

Abstract

backgroundIn the field of biomarker validation with mass spectrometry, controlling the technical variability is a critical issue. In selected reaction monitoring (SRM) measurements, this issue provides the opportunity of using variance component analysis to distinguish various sources of variability. However, in case of unbalanced data (unequal number of observations in all factor combinations), the classical methods cannot correctly estimate the various sources of variability, particularly in presence of interaction. The present paper proposes an extension of the variance component analysis to estimate the various components of the variance, including an interaction component in case of unbalanced data.

resultsWe applied an experimental design that uses a serial dilution to generate known relative protein concentrations and estimated these concentrations by two processing algorithms, a classical and a more recent one. The extended method allowed estimating the variances explained by the dilution and the technical process by each algorithm in an experiment with 9 proteins: L-FABP, 14.3.3 sigma, Calgi, Def.A6, Villin, Calmo, I-FABP, Peroxi-5, and S100A14. Whereas, the recent algorithm gave a higher dilution variance and a lower technical variance than the classical one in two proteins with three peptides (L-FABP and Villin), there were no significant difference between the two algorithms on all proteins.

conclusionsThe extension of the variance component analysis was able to estimate correctly the variance components of protein concentration measurement in case of unbalanced design.

Indexed as

AlgorithmsMass SpectrometryAnalysis of VarianceBiomarkersEnzyme-Linked Immunosorbent AssayHumansProteinsReproducibility of ResultsBiomarkersProteinsExperimental designMass spectrometrySRMTechnical variabilityValidation biomarkersVariance component analysis

Identifiers

PMID29490628
PMCPMC5831836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.